Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the diagnosis of Hyperparathyroidism.

There is National Institute for Health and Care Excellence (NICE) guidance available on the diagnosis, assessment and initial management of hyperparathyroidism in order to support clinicians when a patient presents with possible symptoms. Guidance on diagnostic testing in primary care includes measuring albumin-adjusted serum calcium and measuring parathyroid hormone. Further details can be found at the following link: https://www.nice.org.uk/guidance/ng132

NICE updates guidance regularly and promotes it via its website, newsletters and other media. NICE published its current guidance on hyperparathyroidism in 2019.

There are no current plans to update the guidance published by NICE, which includes diagnosis, assessment and initial management of primary hyperparathyroidism. We would expect patients presenting with symptoms consistent with Primary Hyperparathyroidism to be treated according to clinical need and in line with current guidance.